Quoin Pharmaceuticals logo
Quoin Pharmaceuticals
QNRX | NASDAQ
Chart Builder DCF Calculator
$3.56
-$0.14 (-3.78%)
At close: Nov 16, 2026, 4:00 PM ET
$3.69
+$0.13 (+3.65%)
After-hours: Nov 16, 2026, 4:10 PM ET

Quoin Pharmaceuticals Company Profile

Company profile explained

Company Profile

Quoin Pharmaceuticals, Ltd. operates as a specialized pharmaceutical firm, concentrating its efforts on devising therapeutic solutions for rare and orphan medical conditions. Its flagship offering, QRX003, is a topical lotion specifically formulated to address Netherton Syndrome. Furthermore, the company is advancing QRX004 for the management of dystrophic epidermolysis bullosa, alongside QRX006, a prospective therapy for an additional rare dermatological ailment. The organization maintains its operational base in Ashburn, Virginia.

Key Executives

Name Position
Michael Myers Co-Founder, Chief Executive Officer & Chairman
Denise Carter Co-Founder, Chief Operating Officer & Director
Sally Lawlor Chief Financial Officer

Latest SEC Filings

Date Type Title
Oct 28, 2026 S-3 Filing
Oct 26, 2026 4/A [Amend] Filing
Oct 20, 2026 8-K Current Report
Oct 14, 2026 8-K Current Report
Oct 07, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Oct 02, 2026 DEF 14A Filing
Sep 25, 2026 EFFECT Filing
Sep 25, 2026 424B3 Filing
Sep 22, 2026 PRE 14A Filing
Sep 22, 2026 8-K Current Report
View All SEC Filings ➞
Quoin Pharmaceuticals
Quoin Pharmaceuticals logo
Country United States
IPO Date Aug 1, 2016
Industry Biotechnology
Sector Healthcare
Employees 4
CEO Michael Myers

Contact Details

42127 Pleasant Forest Court Ashburn, Virginia 20148-7349 United States

Stock Details

Ticker Symbol QNRX
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001671502
CUSIP Number 74907L409
ISIN Number US74907L4095
SIC Code 3841

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.